Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer
Cecilia Monge, Changqing Xie, Yuta Myojin, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 2, pp. e005640-e005640
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Exploring treatment options in cancer: Tumor treatment strategies
Beilei Liu, Hongyu Zhou, Licheng Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 186
Biomarkers for immunotherapy of hepatocellular carcinoma
Tim F. Greten, Augusto Villanueva, Firouzeh Korangy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 780-798
Closed Access | Times Cited: 99
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
Qing Li, Shan Geng, Hao Luo, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 51
New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses
Amin Kamrani, Hadi Nasiri, Ali Hassanzadeh, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 20
Immune checkpoint inhibitors in colorectal cancer: limitation and challenges
Suying Yan, Wanting Wang, Zhiqiang Feng, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial
Kelley Coffman, Yuta Myojin, Cecilia Monge, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 1, pp. e008079-e008079
Open Access | Times Cited: 9
The Efficacy of Immune Checkpoint Inhibitors in Microsatellite Stable Colorectal Cancer: A Systematic Review
Deniz Can Güven, Gözde Kavgacı, Enes Erul, et al.
The Oncologist (2024) Vol. 29, Iss. 5, pp. e580-e600
Open Access | Times Cited: 9
Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma
Cecilia Monge, Changqing Xie, Yuta Myojin, et al.
Cancer Medicine (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 7
Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy
Salima Shebbo, Najat Binothman, Manar Darwaish, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Recent progress in combination therapy of oncolytic vaccinia virus
Seyedeh Nasim Mirbahari, Miles Da Silva, Abril Ixchel Muñoz Zúñiga, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Preclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive review
Mengyuan Li, Zhang Minghuan, Qian Ye, et al.
Cancer Biology and Medicine (2023), pp. 1-16
Open Access | Times Cited: 15
Oncolytic Viruses and Immune Checkpoint Inhibitors: The “Hot” New Power Couple
Charlotte Lovatt, Alan L. Parker
Cancers (2023) Vol. 15, Iss. 16, pp. 4178-4178
Open Access | Times Cited: 14
Emerging roles of intratumor microbiota in cancer: tumorigenesis and management strategies
Zhuangzhuang Shi, Zhaoming Li, Mingzhi Zhang
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
The long-term effectiveness and mechanism of oncolytic virotherapy combined with anti-PD-L1 antibody in colorectal cancer patient
Hangyu Zhang, Yiqing Ren, Feiyu Wang, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 9, pp. 1412-1426
Open Access | Times Cited: 4
WNT and TGF-Beta Pathway Alterations in Early-Onset Colorectal Cancer Among Hispanic Populations
Cecilia Monge, Brigette Waldrup, Francisco Carranza, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
A Multiple‐Model‐Informed Drug‐Development Approach for Optimal Regimen Selection of an Oncolytic Virus in Combination With Pembrolizumab
Akihiro Yamada, Mary Choules, Frances A. Brightman, et al.
CPT Pharmacometrics & Systems Pharmacology (2025)
Open Access
Clinical trials on oncolytic viruses
I. V. Golovinov, А. С. Гончарова, A. A. Shulga, et al.
Bulletin of Siberian Medicine (2025) Vol. 23, Iss. 4, pp. 158-168
Open Access
Tumor microbiome: roles in tumor initiation, progression, and therapy
Shengxin Zhang, Jing Huang, Z. X. Jiang, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access
The therapeutic impact of programmed death – 1 in the treatment of colorectal cancer
Pooria Salehi Sangani, Soroush Yazdani, Ghazaleh Khalili‐Tanha, et al.
Pathology - Research and Practice (2024) Vol. 259, pp. 155345-155345
Closed Access | Times Cited: 3
Dose Considerations for Vaccinia Oncolytic Virus Based on Retrospective Reanalysis of Early and Late Clinical Trials
Mefotse Saha Cyrelle Ornella, Jae-Joon Kim, Euna Cho, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1010-1010
Open Access | Times Cited: 3
Targeting TGFβ and Over-Expressing GM-CSF in the Tumor with Oncolytic Adenovirus Inhibits Tumor Growth/Metastases and Augments Immune Checkpoint Inhibitor Response in a Triple Negative Breast Cancer Mouse Model
Nguyễn Thị Thanh Nhàn, Soon Cheon Shin, Beniamin Filimon, et al.
Deleted Journal (2025) Vol. 33, Iss. 1, pp. 200936-200936
Open Access
Pathway-specific genomic alterations in pancreatic cancer across diverse cohorts
Cecilia Monge, Brigette Waldrup, Francisco J. Carranza-Chávez, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
An updated review on immune checkpoint inhibitor-induced colitis: epidemiology, pathogenesis, treatment strategies, and the role of traditional Chinese medicine
Huijing Dong, Yanmei Peng, Xinmeng Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Molecular Alterations in TP53, WNT, PI3K, TGF-Beta, and RTK/RAS Pathways in Gastric Cancer Among Ethnically Heterogeneous Cohorts
Cecilia Monge, Brigette Waldrup, Francisco Carranza, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1075-1075
Open Access
Detecting PI3K and TP53 Pathway Disruptions in Early‐Onset Colorectal Cancer Among Hispanic/Latino Patients
Cecilia Monge, Brigette Waldrup, Sophia Manjarrez, et al.
Cancer Medicine (2025) Vol. 14, Iss. 7
Open Access
Page 1 - Next Page

Scroll to top